E Glenn Armstrong

Title: E Glenn Armstrong: Innovator in Bioassay Technology

Introduction

E Glenn Armstrong is a notable inventor based in San Diego, CA. He is recognized for his contributions to the field of bioassays, particularly through his innovative patent that utilizes monoclonal antibodies. His work has significant implications for the detection of biologically active ligands, which are crucial in various medical applications.

Latest Patents

Armstrong holds a patent for a sensitive bioassay that employs monoclonal antibodies to bind to specific ligands. This invention provides a quantitative assay for determining the presence of human chorionic gonadotropin and luteinizing hormone in a sample. The method involves contacting the sample with both the receptor and a monoclonal antibody, forming a complex that allows for the detection of the ligand. This technology not only enhances the accuracy of biological assays but also offers kits for quantitative analysis of these ligands and their receptors.

Career Highlights

Throughout his career, Armstrong has worked with prestigious institutions, including Columbia University and the University of Medicine and Dentistry of New Jersey. His experience in these organizations has contributed to his expertise in the field of bioassays and immunology.

Collaborations

Armstrong has collaborated with notable colleagues such as Robert E Canfield and William R Moyle. These partnerships have likely enriched his research and development efforts in the realm of bioassay technology.

Conclusion

E Glenn Armstrong's innovative work in the field of bioassays demonstrates his significant contributions to medical diagnostics. His patent for a sensitive bioassay using monoclonal antibodies showcases the potential for improved detection methods in healthcare.